Use of DNA Testing and Gene Expression Profiling to Help Transition Kidney Transplant Recipients to Belatacept-only Immunosuppression
Clinical trial NCT06336863 · ENROLLING_BY_INVITATION
Trial details
- NCT number
- NCT06336863
- Sponsor
- University of Texas Southwestern Medical Center
- Status
- ENROLLING_BY_INVITATION
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2024-06-14
- Primary completion
- 2026-08-01
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.